Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tricuspid Valve Clipping in Severe Tricuspid Regurgitation
NCT07433504Recruiting
- Sponsor
- Huihe Medical
- Start
- Jan 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Randomised, open-label trial in tricuspid regurgitation (2 arms), sponsored by Huihe Medical. Primary endpoint: Rate of subjects free of all-cause death or tricuspid valve reoperation, free of heart failure readmission, and with ≥15-point improvement in the Kansas City Cardiomyopathy Questionnaire score at 1 year. Started Jan 2026; status: recruiting.
02
Conditions
tricuspid regurgitation
Beyond the preview
Go deeper on NCT07433504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07433504.